Taken together, thiswork not only revealed a novel STAT3 Tyr705 and Ser727 phosphorylationinhibitor as a promising new therapeutic agent for pancreatic cancer,but also provided insights into approaches to the development of STAT3Tyr705 and Ser727 phosphorylation inhibitors. This evidence concerns the gene STAT3 and pancreatic neoplasm.